Literature DB >> 19759135

Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus.

Jonathan D Finn1, Jennifer Bassett, James B Millar, Natalie Grinshtein, Teng Chih Yang, Robin Parsons, Carole Evelegh, Yonghong Wan, Robin J Parks, Jonathan L Bramson.   

Abstract

Previous studies determined that the CD8(+) T-cell response elicited by recombinant adenovirus exhibited a protracted contraction phase that was associated with long-term presentation of antigen. To gain further insight into this process, a doxycycline-regulated adenovirus was constructed to enable controlled extinction of transgene expression in vivo. We investigated the impact of premature termination of transgene expression at various time points (day 3 to day 60) following immunization. When transgene expression was terminated before the maximum response had been attained, overall expansion was attenuated, yielding a small memory population. When transgene expression was terminated between day 13 and day 30, the memory population was not sustained, demonstrating that the early memory population was antigen dependent. Extinction of transgene expression at day 60 had no obvious impact on memory maintenance, indicating that maintenance of the memory population may ultimately become independent of transgene expression. Premature termination of antigen expression had significant but modest effects on the phenotype and cytokine profile of the memory population. These results offer new insights into the mechanisms of memory CD8(+) T-cell maintenance following immunization with a recombinant adenovirus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759135      PMCID: PMC2786755          DOI: 10.1128/JVI.00593-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.

Authors:  Teng Chih Yang; Kelley Dayball; Yong Hong Wan; Jonathan Bramson
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Recall proliferation potential of memory CD8+ T cells and antiviral protection.

Authors:  Martin F Bachmann; Petra Wolint; Katrin Schwarz; Annette Oxenius
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

3.  Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.

Authors:  Martin F Bachmann; Petra Wolint; Katrin Schwarz; Petra Jäger; Annette Oxenius
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

4.  The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity.

Authors:  Teng-Chih Yang; James Millar; Timothy Groves; Natalie Grinshtein; Robin Parsons; Shunsuke Takenaka; Yonghong Wan; Jonathan L Bramson
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

5.  Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.

Authors:  Wentao Gao; Adam C Soloff; Xiuhua Lu; Angela Montecalvo; Doan C Nguyen; Yumi Matsuoka; Paul D Robbins; David E Swayne; Ruben O Donis; Jacqueline M Katz; Simon M Barratt-Boyes; Andrea Gambotto
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.

Authors:  Stefania Capone; Annalisa Meola; Bruno Bruni Ercole; Alessandra Vitelli; Monica Pezzanera; Lionello Ruggeri; Mary Ellen Davies; Rosalba Tafi; Claudia Santini; Alessandra Luzzago; Tong-Ming Fu; Andrew Bett; Stefano Colloca; Riccardo Cortese; Alfredo Nicosia; Antonella Folgori
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 7.  Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines.

Authors:  Zhou Xing; Michael Santosuosso; Sarah McCormick; Teng-Chih Yang; James Millar; Mary Hitt; Yonghong Wan; Jonathan Bramson; H Martin Vordermeier
Journal:  Curr Gene Ther       Date:  2005-10       Impact factor: 4.391

8.  Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

Authors:  Vladimir P Badovinac; Kelly A N Messingham; Ali Jabbari; Jodie S Haring; John T Harty
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

9.  Evaluation of CD62L expression as a marker for vaccine-elicited memory cytotoxic T lymphocytes.

Authors:  Shawn S Jackson; Jörn E Schmitz; Marcelo J Kuroda; Paul F McKay; Shawn M Sumida; Kristi L Martin; Faye Yu; Michelle A Lifton; Darci A Gorgone; Norman L Letvin
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

Review 10.  Adenovirus as vehicle for anticancer genetic immunotherapy.

Authors:  P Gallo; S Dharmapuri; B Cipriani; P Monaci
Journal:  Gene Ther       Date:  2005-10       Impact factor: 5.250

View more
  34 in total

1.  Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.

Authors:  Lukas Flatz; Cheng Cheng; Lingshu Wang; Kathryn E Foulds; Sung-Youl Ko; Wing-Pui Kong; Rahul Roychoudhuri; Wei Shi; Saran Bao; John-Paul Todd; Mohammed Asmal; Ling Shen; Mitzi Donaldson; Stephen D Schmidt; Jason G D Gall; Daniel D Pinschewer; Norman L Letvin; Srinivas Rao; John R Mascola; Mario Roederer; Gary J Nabel
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.

Authors:  Jennifer D Bassett; Stephanie L Swift; Heather VanSeggelen; Joanne A Hammill; A J Robert McGray; Carole Evelegh; Yonghong Wan; Jonathan L Bramson
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

3.  Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.

Authors:  Paula Ordonhez Rigato; Bruna C de Alencar; José Ronnie C de Vasconcelos; Mariana R Dominguez; Adriano F Araújo; Alexandre V Machado; Ricardo T Gazzinelli; Oscar Bruna-Romero; Mauricio M Rodrigues
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

4.  Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding.

Authors:  Natalie F Nidetz; Tom M Gallagher; Christopher M Wiethoff
Journal:  Virology       Date:  2017-12-27       Impact factor: 3.616

5.  Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression.

Authors:  Matthew J Johnson; Niklas K Björkström; Constantinos Petrovas; Frank Liang; Jason G D Gall; Karin Loré; Richard A Koup
Journal:  Vaccine       Date:  2013-12-08       Impact factor: 3.641

6.  Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation.

Authors:  Maria Abildgaard Steffensen; Peter Johannes Holst; Sanne Skovvang Steengaard; Benjamin Anderschou Holbech Jensen; Christina Bartholdy; Anette Stryhn; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

7.  Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Authors:  Graeme E Price; Mark R Soboleski; Chia-Yun Lo; Julia A Misplon; Mary R Quirion; Katherine V Houser; Melissa B Pearce; Claudia Pappas; Terrence M Tumpey; Suzanne L Epstein
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

8.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Authors:  Nicholas M Provine; Rafael A Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N Borducchi; Kathleen B Yates; Peter Abbink; Marinela Kirilova; David Ng'ang'a; Jonathan Bramson; W Nicholas Haining; Dan H Barouch
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

9.  Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.

Authors:  Kylie M Quinn; Andreia Da Costa; Ayako Yamamoto; Dana Berry; Ross W B Lindsay; Patricia A Darrah; Lingshu Wang; Cheng Cheng; Wing-Pui Kong; Jason G D Gall; Alfredo Nicosia; Antonella Folgori; Stefano Colloca; Riccardo Cortese; Emma Gostick; David A Price; Carmen E Gomez; Mariano Esteban; Linda S Wyatt; Bernard Moss; Cecilia Morgan; Mario Roederer; Robert T Bailer; Gary J Nabel; Richard A Koup; Robert A Seder
Journal:  J Immunol       Date:  2013-02-06       Impact factor: 5.422

10.  Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway.

Authors:  Rong Wang; Aizhang Xu; Xueying Zhang; Jie Wu; Andrew Freywald; Jianqing Xu; Jim Xiang
Journal:  Cell Mol Immunol       Date:  2016-06-06       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.